PAUL RASHID: Open Payments
NPI 1023223179 · ATLANTIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,147 in 21 payments from 8 companies in 2025. Trend: 2023 $1,189 · 2024 $1,607 · 2025 $1,147
Food & beverage: $1,147
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $382 |
| Otsuka America Pharmaceutical, Inc. | 5 | $208 |
| Janssen Pharmaceuticals, Inc | 3 | $197 |
| Teva Pharmaceuticals USA, Inc. | 3 | $156 |
| LivaNova USA, Inc. | 1 | $117 |
| ABBVIE INC. | 2 | $47 |
| Alkermes, Inc. | 1 | $27 |
| Corium, LLC | 2 | $14 |
Products named: CAPLYTA, REXULTI, INVEGA SUSTENNA, AUSTEDO XR, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, VRAYLAR, SPRAVATO, ABILIFY MAINTENA.
Industry payments across FL — which companies pay providers there.
